Low Cardiac Output Syndrome
19
2
2
11
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 19 trials
100.0%
+13.5% vs benchmark
42%
8 trials in Phase 3/4
9%
1 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (19)
Intraoperative Global Longitudinal Strain and Global Longitudinal Strain Rate as Predictors of Unfavorable Outcome in On-Pump Mitral Surgery
Landiolol in Mitral Valve Surgery
Patients With Low Cardiac Output Syndrome Undergoing Local Dental Anesthesia
Nitric Oxide During Bypass for Arterial Switch Operation
Anesthesia Standard Operating Procedure During On-pump Coronary Artery Bypass Grafting
Autologous Umbilical Cord Blood Treatment of Neonate With CHD
Exogenous Ketones for Acutely Decompensated HEart Failure
Milrinone Versus Dobutamine in Critically Ill Patients
Outcome of Patients Treated With IABP
Prognostic Markers of Inflammation in Infants Undergoing Cardiopulmonary Bypass
Prophylactic Use of Milrinone After Congenital Heart Surgery in Infants
Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass
Levosimendan in High Risk Patients Undergoing Cardiac Surgery
Remote Ischemic Preconditioning in High Risk Cardiovascular Surgery Patients
Levosimendan Administration in Neonates With Transposition of the Great Arteries
Two Inodilators Postsurgery in Neonates
Levosimendan in Congenital Cardiac Surgery
How Much Cardiac Output is Enough?
Prophylactic Use of Levosimendan Versus Milrinone in Open Heart Surgery in Infants